427 related articles for article (PubMed ID: 6177933)
1. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
Shepherd AN; Campbell BC; Reid JL
J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
[TBL] [Abstract][Full Text] [Related]
2. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic and humoral effects of lower body negative pressure in normal, sodium-replete man during angiotensin-converting enzyme inhibition with captopril.
Rasmussen S; Hesse B; Bonde-Petersen F; Damkjaer Nielsen M; Christensen NJ; Giese J; Warberg J
Scand J Clin Lab Invest; 1986 Feb; 46(1):81-8. PubMed ID: 3006218
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
[TBL] [Abstract][Full Text] [Related]
6. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
Hashimoto H; Hiwada K; Kokubu T
Jpn Circ J; 1981 Feb; 45(2):176-80. PubMed ID: 6262543
[TBL] [Abstract][Full Text] [Related]
7. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
[TBL] [Abstract][Full Text] [Related]
8. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
[No Abstract] [Full Text] [Related]
10. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
11. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin converting enzyme inhibition with SQ 14 225 on blood pressure in sheep.
Stewart KW; Coghlan JP; Denton DA; Fei DT; Mason RT; Scoggins BA; Whitworth JA
Clin Exp Hypertens (1978); 1981; 3(1):159-71. PubMed ID: 6258888
[TBL] [Abstract][Full Text] [Related]
13. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
14. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
[TBL] [Abstract][Full Text] [Related]
15. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
Ogihara T; Maruyama A; Hata T; Mikami H; Nakamaru M; Naka T; Ohde H; Kumahara Y
Clin Pharmacol Ther; 1981 Sep; 30(3):328-35. PubMed ID: 6268347
[TBL] [Abstract][Full Text] [Related]
16. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
17. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
18. Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans.
Ottesen MM; Worck R; Ibsen H
Blood Press; 1997 Jan; 6(1):29-34. PubMed ID: 9116923
[TBL] [Abstract][Full Text] [Related]
19. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
[No Abstract] [Full Text] [Related]
20. Acute effects of captopril on serum angiotensin-converting enzyme activity, the renin-aldosterone system and blood pressure in patients with sarcoidosis.
Mizuno K; Gotoh M; Matsui J; Nagasawa S; Fukuchi S
Tohoku J Exp Med; 1983 May; 140(1):107-8. PubMed ID: 6306866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
